Cargando…
Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non‐small cell lung cancer
This study was conducted to investigate the relationship between genetic variants in LKB1/AMPK/mTOR pathway and treatment outcomes of patients with non‐small cell lung cancer (NSCLC) treated with chemotherapy. A total of 379 patients with NSCLC who underwent first‐line paclitaxel‐cisplatin chemother...
Autores principales: | Choi, Sun Ha, Do, Sook Kyung, Lee, Shin Yup, Choi, Jin Eun, Kang, Hyo‐Gyoung, Hong, Mi Jeong, Lee, Jang Hyuck, Lee, Won Kee, Jeong, Ji Yun, Shin, Kyung Min, Do, Young Woo, Lee, Eung Bae, Park, Ji Eun, Lee, Yong Hoon, Seo, Hyewon, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715851/ https://www.ncbi.nlm.nih.gov/pubmed/36239337 http://dx.doi.org/10.1111/1759-7714.14688 |
Ejemplares similares
-
Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
por: Lee, Sunwoong, et al.
Publicado: (2023) -
Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma
por: Lee, Yong Hoon, et al.
Publicado: (2023) -
Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
por: Hong, Mi Jeong, et al.
Publicado: (2022) -
The effect of susceptibility variants, identified in never-smoking female lung cancer cases, on male smokers
por: Yoo, Seung Soo, et al.
Publicado: (2020) -
Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2023)